--> --> -->

Global Nasal Drug Delivery Mode Market Analysis, 2020

By Therapeutic Application (Asthma, Rhinitis, Other), By Dosage Form (Powder, Gel, Spray, Gel), By Container Type (Pressurized Container, Non-Pressurized Container), By System Type (Multi-Dose, Bi-Dose, Unit Dose), By End-User (Hospitals, Homecare settings), By Distribution (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Brazil, Argentina, Spain, UK, Germany, France, Italy, China, India, Japan, South Korea, South east Asia, UAE, Saudi Arabia, Turkey, South Africa), By Company (Merck & Co., Inc., GlaxoSmithKline Plc, AstraZeneca, Johnson & Johnson Services Inc., Mystic Pharmaceuticals, Bausch Health, BD, 3M, AptarGroup, Inc., OptiNose US, Inc., Dr. Reddy’s Laboratories Ltd., Flo Nasal Products, Cadila Pharmaceuticals, PendoPharm Inc, Neurelis, Inc. etc.)

  • Healthcare
  • Sep 2020
  • 167
  • HC22039